Einfluss der Taxane auf die Therapiesequenz des Magenkarzinoms
NEO- AND ADJUVANT TREATMENT FOR GASTRIC CANCER: THE ROLE OF CHEMOTHERAPY
Cancers | Free Full-Text | Completion of FLOT Therapy, Regardless of Tumor Regression, Significantly Improves Overall Survival in Patients with Esophageal Adenocarcinoma
Overall survival for FLOT-first versus surgery-first in patients with... | Download Scientific Diagram
Cancers | Free Full-Text | Beyond the Guidelines: The Grey Zones of the Management of Gastric Cancer. Consensus Statements from the Gastric Cancer Italian Network (GAIN)
RECENT ADVANCES IN COMBINATION CHEMOTHERAPY: METASTATIC COLON CANCER
Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer | British Journal of Cancer
Therapieoptionen beim oligometastasierten Magenkarzinom | SpringerLink
2038-Gastric and gastroesophageal neoadjuvant/adjuvant FLOT | eviQ
NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma—Very good response predominantly in patients with intestinal type tumors - Schulz - 2015 -
PDF) Resektion beim fortgeschrittenen Adenokarzinom des Magens und des Ösophagus: Erweiterung der Indikation
FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy | SpringerLink
PDF) Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer
Trastuzumab with FLOT Regimen for the Perioperative Treatment of Resec | CMAR
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction –
PDF) Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer
Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR) | BMC Cancer | Full Text
Cancers | Free Full-Text | Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions
Efficacy and Safety of FLOT regimen vs. DCF, FOLFOX, and ECF regimens as Perioperative Chemotherapy Treatments for Resectable Gastric Cancer Patients | medRxiv
Systematic review and meta-analysis of docetaxel perioperative chemotherapy regimens in gastric and esophagogastric tumors | Scientific Reports
RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV | BMC
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a ...
PDF) Perioperative FLOT chemotherapy plus surgery for oligometastatic esophagogastric adenocarcinoma: surgical outcome and overall survival
